FDA

It is possible that the world may never eradicate Covid-19, even with vaccines, not unlike the flu.

SINGAPORE (Sept 20): QT Vascular says it has been granted a conditional Investigational Device Exemption approval from the Food and Drug Administration to commence clinical trials for its Chocolate Touch drug-coated balloon.

SINGAPORE (June 27): QT Vascular’s Chocolate XD propercutaneous transluminal coronary angioplasty (PTCA) balloon has received approvals from the US Food and Drug Administration for use in coronary interventions.